| 46 |
Evaluation of exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension |
Department of Chest Diseases |
2024 |
| 47 |
Effect of Residual Myocardial Ischemia on Recovery of Left Ventricular Function after Primary Percutaneous Coronary Intervention |
Department of Cardiology |
2024 |
| 48 |
Can cross-sectional imaging replace diagnostic venography in pelvic venous disorder (PeVD)? |
Department of Diagnostic Radiology |
2024 |
| 49 |
Assessment of Intra-operative and Early Post-operative Complications of Laser in–situ Keratomileusis |
Department of Ophthalmology |
2024 |
| 50 |
Improving frailty assessment: the task is not finished |
Department of Chest Diseases |
2023 |
| 51 |
Graves’ disease in children: an update |
Department of Pediatrics |
2023 |
| 52 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 53 |
Quercetin Alleviated Inflammasome-Mediated Pyroptosis and Modulated the mTOR/P70S6/P6/eIF4E/4EBP1 Pathway in Ischemic Stroke |
Department of Pharmacology |
2023 |
| 54 |
Frequency of Rifampicin-resistant Mycobacterium Tuberculosis by GeneXpert MTB/RIF assay and its Correlates among 2605 Probable Tuberculosis Patients in Upper Egypt |
Department of Chest Diseases |
2023 |
